← Back to Search

Peer Navigation + mHealth for HIV/AIDS, STIs, and Hepatitis C Testing

N/A

Recruiting

Led By Scott D. Rhodes, Ph.D, MPH

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Report being assigned male sex at birth and having had sex with at least 1 man in the past 12 months

Be ≥18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Awards & highlights

Study Summary

This trial will test a new intervention to increase HIV, STI, and HCV testing among GBMSM and transgender women in rural Appalachia.

Who is the study for?

This trial is for adults over 18 living in rural Appalachian counties, assigned male at birth and have had sex with a man in the past year. They must consent to participate. It's aimed at racially/ethnically diverse gay, bisexual men, and transgender women.Check my eligibility

What is being tested?

The study tests a combined intervention of peer navigation support and mobile health (mHealth) technology to improve HIV, STI, and HCV prevention and care services among participants compared to those receiving delayed intervention.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like peer support and mobile health technologies rather than drugs or medical procedures, traditional side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was assigned male at birth and have had sex with a man in the last year.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline).

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediate post-intervention (12 months post-baseline), and 12-month follow-up (24 months post-baseline). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who have HCV testing

Number of participants who have HIV testing

Number of participants who have Hepatitis C Virus (HCV) testing

+3 more

Secondary outcome measures

Number of participants who use HCV treatment services

Number of participants who use HIV care services

Number of participants who use STI treatment services

+3 more

Trial Design

2Treatment groups

Active Control

Group I: intervention groupActive Control2 Interventions

7 community health leaders; 56 social network members

Group II: delayed-interventionActive Control2 Interventions

7 community health leaders; 56 social network members

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,241 Previous Clinical Trials

1,004,096 Total Patients Enrolled

3 Trials studying Hepatitis C

332 Patients Enrolled for Hepatitis C

Scott D. Rhodes, Ph.D, MPHPrincipal InvestigatorWake Forest University Health Sciences

Media Library

mHealth Clinical Trial Eligibility Overview. Trial Name: NCT04378439 — N/A

Hepatitis C Research Study Groups: intervention group, delayed-intervention

Hepatitis C Clinical Trial 2023: mHealth Highlights & Side Effects. Trial Name: NCT04378439 — N/A

mHealth 2023 Treatment Timeline for Medical Study. Trial Name: NCT04378439 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there openings for enrollees in this trial?

"Affirmative, the clinicaltrials.gov database indicates that this research project is presently enrolling participants. Initially posted on April 1st 2022 and most recently revised by April 27th 2022, 141 candidates must be recruited from one medical location for participation in the trial."

Answered by AI

To what extent has this investigation attracted participants?

"Affirmative, according to information on clinicaltrials.gov this medical trial is still recruiting participants and was initially posted on April 1st 2022. With the last update happening on April 27th of that same year, 141 patients are needed from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Appalachian Partnership to Reduce Disparities (Aim 2)

2022. "Appalachian Partnership to Reduce Disparities (Aim 2)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04378439.

All > Hepatitis C > Aids